MedTrace Logo

Bioceramic Sealer as an Obturation Material in Retained Primary Molars

NCT07772986 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-20

No results posted yet for this study

Summary

The goal of this single arm clinical trial was to to explore the clinical feasibility and radiographic outcome of the injectable bioceramic sealer as an obturation material for primary molars with congenitally missing permanent successors. The main question it aimed to answer was:

Does injectable bioceramic sealers can be used as an obturation material for primary molars with congenitally missing permanent successors?

Researchers used a commercially available bioceramic sealer as a sole obturation material for pulpectomized primary molars with congenitally missing permanent successors

Eligible participants underwent pulpectomy treatment and followed up at 3,6,12 and 24 months postoperatively to evaluate clinical and radiographic success.

Conditions

  • Pulpectomy
  • Bioceramic Sealer

Interventions

BIOLOGICAL

bioceramic sealer

the root canals were obturated solely with Ceraseal bioceramic sealer

Sponsors & Collaborators

  • Osama Seif El-Nasr Hussein Gad El-Hak

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2026-06-24
Completion
2026-06-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07772986 on ClinicalTrials.gov